BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36939643)

  • 21. Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.
    Pal A; Farmer AJ; Dudley C; Selwood MP; Barrow BA; Klyne R; Grew JP; McCarthy MI; Gloyn AL; Owen KR
    Diabetes Care; 2010 Feb; 33(2):252-7. PubMed ID: 19933992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Changes in the Glucokinase Gene (GCK) Associated with the Diagnosis of Maturity Onset Diabetes of the Young (MODY) in Pregnant Women and Newborns.
    Lepore C; Damaso E; Suazo V; Queiroz R; Junior RL; Moisés E
    Curr Diabetes Rev; 2022; 18(6):e060821195358. PubMed ID: 34365926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and clinical characterization of glucokinase maturity-onset diabetes of the young (GCK-MODY) in Japanese patients.
    Kawakita R; Hosokawa Y; Fujimaru R; Tamagawa N; Urakami T; Takasawa K; Moriya K; Mizuno H; Maruo Y; Takuwa M; Nagasaka H; Nishi Y; Yamamoto Y; Aizu K; Yorifuji T
    Diabet Med; 2014 Nov; 31(11):1357-62. PubMed ID: 24804978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical profiling and screening for HNF4α and GCK gene mutations in Kashmiri patients with maturity-onset diabetes of the young (MODY).
    Firdous P; Hassan T; Nissar K; Masoodi SR; Ganai BA
    Prim Care Diabetes; 2022 Apr; 16(2):325-332. PubMed ID: 35131168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular risk assessment by coronary artery calcium score in subjects with maturity-onset diabetes of the young caused by glucokinase mutations.
    Franco LF; Szarf G; Dotto RP; Dib SA; Moises RS; Giuffrida FMA; Reis AF
    Diabetes Res Clin Pract; 2021 Jun; 176():108867. PubMed ID: 34023340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Pesto" Mutation: Phenotypic and Genotypic Characteristics of Eight GCK/MODY Ligurian Patients.
    Salina A; Bassi M; Aloi C; Strati MF; Bocciardi R; d'Annunzio G; Maghnie M; Minuto N
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating ghrelin level is higher in HNF1A-MODY and GCK-MODY than in polygenic forms of diabetes mellitus.
    Nowak N; Hohendorff J; Solecka I; Szopa M; Skupien J; Kiec-Wilk B; Mlynarski W; Malecki MT
    Endocrine; 2015 Dec; 50(3):643-9. PubMed ID: 25987348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
    Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
    Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
    Østoft SH
    Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2).
    Spégel P; Ekholm E; Tuomi T; Groop L; Mulder H; Filipsson K
    Diabetes; 2013 Feb; 62(2):653-61. PubMed ID: 23139355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new clinical screening strategy and prevalence estimation for glucokinase variant-induced diabetes in an adult Chinese population.
    Ma Y; Han X; Zhou X; Li Y; Gong S; Zhang S; Cai X; Zhou L; Luo Y; Li M; Liu W; Zhang X; Ren Q; Ji L
    Genet Med; 2019 Apr; 21(4):939-947. PubMed ID: 30245511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GCK monogenic diabetes and gestational diabetes: possible diagnosis on clinical grounds.
    Flack JR; Ross GP; Cheung NW
    Diabet Med; 2015 Dec; 32(12):1596-601. PubMed ID: 26043405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Maturity-onset diabetes of the young 2 with a novel mutation of glucokinase gene in a Chinese boy and the clinical follow-up].
    Li X; Liu L; Liang C; Sheng H; Zhao X
    Zhonghua Er Ke Za Zhi; 2014 Nov; 52(11):867-71. PubMed ID: 25582477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Comparison of Daily Glucose Fluctuation Between GCK-MODY and Type 2 Diabetes Using Continuous Glucose Monitoring Technology. Diabetes 2023;72:812-818.
    Amanda DK
    Diabetes; 2024 May; 73(5):e1-e2. PubMed ID: 38640414
    [No Abstract]   [Full Text] [Related]  

  • 36. Diagnosis and management of glucokinase monogenic diabetes in pregnancy: current perspectives.
    Rudland VL
    Diabetes Metab Syndr Obes; 2019; 12():1081-1089. PubMed ID: 31372018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes.
    Chow E; Wang K; Lim CKP; Tsoi STF; Fan B; Poon E; Luk AOY; Ma RCW; Ferrannini E; Mari A; Chen L; Chan JCN
    Diabetes; 2023 Feb; 72(2):299-308. PubMed ID: 36342518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evolving spectrum of diabetes in a woman with GCK-MODY.
    Garrahy A; Mijares Zamuner MB; Byrne MM
    Endocrinol Diabetes Metab Case Rep; 2019 Jan; 2019():. PubMed ID: 30608898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Type 2 diabetes on Glucokinase diabetes (GCK-MODY) phenotype in a Roma (Gypsy) family - case report.
    Stanik J; Kusekova M; Huckova M; Valentinova L; Masindova I; Stanikova D; Ferenczova J; Gasperikova D; Klimes I
    Endocr Regul; 2012 Apr; 46(2):99-105. PubMed ID: 22540858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localized increases in CEPT1 and ATGL elevate plasmalogen phosphatidylcholines in HDLs contributing to atheroprotective lipid profiles in hyperglycemic GCK-MODY.
    Wang X; Lam SM; Cao M; Wang T; Wang Z; Yu M; Li B; Zhang H; Ping F; Song G; Feng K; Zhang Q; Xu J; Zhou L; Deng M; Zhai X; Xiao X; Shui G
    Redox Biol; 2021 Apr; 40():101855. PubMed ID: 33450726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.